This is a StreetInsider.com Premium Only Page

(ZLAB) – PRNewswire

Feb 25, 2024 09:32 PM Qiming Venture Partners Becomes a UN PRI Signatory

Sep 26, 2023 01:33 PM Qiming Venture Partners' portfolio company Tuhu Car Successfully Listed on the Hong Kong Stock Exchange

Feb 4, 2023 12:15 AM Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq

Jul 24, 2022 11:55 PM Qiming's Portfolio Company InventisBio Lists on STAR Market

Jul 10, 2022 09:00 PM Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion

Apr 12, 2022 09:20 PM Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List

Mar 29, 2022 10:18 PM Qiming's Portfolio Company Rendu Biotechnology Lists on STAR Market

Mar 22, 2022 12:08 AM Qiming's Portfolio Company Arrail Group Lists on Main Board of HKEX

Mar 1, 2022 08:00 PM Qiming Venture Partners Welcomes David Chu as IR Partner

Jan 7, 2022 03:06 AM Qiming Venture Partners Announces Annual Promotions

Jan 3, 2022 11:06 PM Shiyu Wang Rejoins Qiming Venture Partners as Partner, Co-Leads TMT Team

Dec 10, 2021 12:46 AM Qiming's Portfolio Company CANbridge Pharmaceuticals Lists on Main Board of HKEx

Nov 15, 2021 01:50 AM Qiming's Portfolio Company Aohua Endoscopy Lands on STAR Market

Nov 9, 2021 08:00 AM Blueprint Medicines and Zai Lab Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China

Oct 19, 2021 01:46 AM Qiming's Portfolio Company Microtech Medical Lists on Main Board of HKEx

Oct 14, 2021 11:55 PM Qiming's Portfolio Company Abbisko Lists on Main Board of HKEx

Oct 13, 2021 10:00 AM Geneseeq and Zai Lab Announce Strategic Collaboration to Advance Cancer Drug R&D

Sep 24, 2021 02:02 AM Qiming's Portfolio Company Broncus Lists on Main Board of HKEx

Aug 25, 2021 08:30 AM Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market

Aug 16, 2021 02:07 AM Qiming's Portfolio Company Sino Biological Lists on Shenzhen's ChiNext Market

Jun 1, 2021 07:30 AM Mirati Therapeutics and Zai Lab Enter Into a Collaboration to Develop and Commercialize Adagrasib in Greater China

Apr 28, 2021 06:23 AM Qiming's Portfolio Company Fanli.com Goes Public on Shanghai Stock Exchange

Apr 13, 2021 08:52 AM Qiming's Duane Kuang, Nisa Leung Named on 2021 Forbes Midas List

Mar 26, 2021 10:13 PM Qiming's Portfolio Company Zhihu Lists on New York Stock Exchange

Mar 19, 2021 09:00 PM Qiming's Portfolio Company Connect Biopharma Lists on Nasdaq

Feb 17, 2021 10:59 PM First Cancer Early Screening Company Listed on HKEX as New Horizon Health Debuts

Jan 25, 2021 09:07 PM Qiming Venture Partners Closes RMB Fund VI at RMB 2.852 billion

Jan 7, 2021 02:58 AM Qiming Venture Partners' Portfolio Company APT Medical Listed on STAR Board of Shanghai Stock Exchange

Nov 20, 2020 12:34 AM Qiming's Portfolio Company Antengene Lists on Main Board of HKEX

Nov 18, 2020 08:10 AM Qiming Venture Partners Announces Final Closing of US$ 1.2 Billion Fund VII

Nov 8, 2020 07:00 PM Inmagene Biopharmaceuticals closed $21 million Series B financing, making the total raised to date over $40 million

Sep 27, 2020 11:21 PM Qiming's Portfolio Company Zai Lab Lists on Main Board of HKEX

Jul 19, 2020 08:00 PM Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

Jun 28, 2020 11:14 PM Qiming's Portfolio Company Gan & Lee Pharmaceuticals Lands A-Shares Main Board

Jun 22, 2020 12:09 AM Qiming's Portfolio Company SinocellTech Lands on STAR Market

May 5, 2020 06:30 AM Regeneron Reports First Quarter 2020 Financial and Operating Results

Apr 14, 2020 09:10 AM Qiming's Nisa Leung and Duane Kuang Named on 2020 Forbes Midas List

Apr 8, 2020 09:11 PM Qiming Venture Partners Raises $1.1 Billion Fund VII

Apr 8, 2020 06:00 AM Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody)

Mar 5, 2020 05:35 AM Qiming's Portfolios Fight the Novel Coronavirus